Scilex Holding (SCLXW) Gross Margin (2022 - 2026)
Scilex Holding (SCLXW) recorded quarterly Gross Margin of 48.29% in Q1 2026, up 5.0% quarter-over-quarter from 45.99% in Q4 2025, and down 2403.0% on a YoY basis from 2.1% in Q1 2025.
Scilex Holding (SCLXW) Gross Margin (2022 - 2026) Analysis & Trends
Scilex Holding's Gross Margin history runs 5 years deep, the most recent figure standing at 48.29% for Q1 2026.
- In Q1 2026, Gross Margin fell 2403.0% year-over-year to 48.29%; the TTM figure through Mar 2026 stood at 59.69% (down 1224.0% YoY), while the FY2025 annual figure was 65.02%, down 549.0% from the prior year.
- Gross Margin was 48.29% for Q1 2026 at Scilex Holding, up from 45.99% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 83.21% in Q1 2022 to a low of 45.99% in Q4 2025.
- Historically, Gross Margin has averaged 67.2% across 5 years, with a median of 66.94% in 2025.
- The sharpest annual moves came in 2025 and 2026: Gross Margin jumped 760 bps in 2025, then plunged 2403 bps in 2026.
- A 5-year view of Gross Margin shows it stood at 62.14% in 2022, then grew by 7 bps to 66.42% in 2023, then climbed by 3 bps to 68.52% in 2024, then sank by 33 bps to 45.99% in 2025, then advanced by 5 bps to 48.29% in 2026.
- The last three Gross Margin figures came in at 48.29% (Q1 2026), 45.99% (Q4 2025), and 68.48% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 93,699,046.73 Bn | 93,699,041.77 Bn | 7.76 Bn | 75.42% |
| 2 | Eli Lilly | 1,012.06 Bn | 1,006.77 Bn | 16.22 Bn | 81.93% |
| 3 | Johnson & Johnson | 560.67 Bn | 538.62 Bn | 15.96 Bn | 66.31% |
| 4 | AbbVie | 402.20 Bn | 392.85 Bn | 10.78 Bn | 71.88% |
| 5 | Merck | 298.59 Bn | 292.94 Bn | 12.09 Bn | 74.24% |
| 6 | Amgen | 188.77 Bn | 176.74 Bn | 5.87 Bn | 68.16% |
| 7 | Gilead Sciences | 160.22 Bn | 152.49 Bn | 5.52 Bn | 79.24% |
| 8 | Pfizer | 148.19 Bn | 135.42 Bn | -1.21 Bn | -51.69% |
| 9 | Bristol Myers Squibb | 116.72 Bn | 106.26 Bn | 8.07 Bn | 70.22% |
| 10 | Scilex Holding | - | - | 4.15 Mn | 48.29% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 48.29% |
| Dec 31, 2025 | 45.99% |
| Sep 30, 2025 | 68.48% |
| Jun 30, 2025 | 66.94% |
| Mar 31, 2025 | 72.32% |
| Dec 31, 2024 | 68.52% |
| Sep 30, 2024 | 73.90% |
| Jun 30, 2024 | 73.18% |
| Mar 31, 2024 | 64.72% |
| Dec 31, 2023 | 66.42% |
| Sep 30, 2023 | 66.47% |
| Jun 30, 2023 | 66.80% |
| Mar 31, 2023 | 66.07% |
| Dec 31, 2022 | 62.14% |
| Sep 30, 2022 | 68.26% |
| Jun 30, 2022 | 80.71% |
| Mar 31, 2022 | 83.21% |